Omni One, LLC signs agreement today with CustomQuest to market Diabetain® and OmiWafer® Novi, Michigan, March 24, 2015– Omni One, LLC has signed an agreement with CustomQuest to distribute Diabetain® and OmiWafer® to its customers in the US. “We welcome and are very excited about this arrangement and associated opportunities. CustomQuest is a reputable organization. […]
Omni One, LLC signed an agreement today with Automated Management, LLC
March 24, 2015Omni One, LLC signs agreement today with Automated Management to distribute Diabetain® and OmiWafer® Novi, Michigan, March 24, 2015– Omni One, LLC has signed an agreement with Automated Management to distribute Diabetain® and OmiWafer® to its customers in the US. “Automated Management is a specialty distributor serving Micro-Markets, C Stores, vending machines, airport shops, office […]
Learning How To Control Your Type 2 Diabetes Daily, Part 1
September 30, 2014Controlling diabetes is a continuing process. In doing so, the consistency and discipline could be compared to that of a shop owner. Shop owners have to open their shop every day, manage the store on a consistent basis throughout the day and respond to customers. The net result of those efforts is a flourishing business. […]
Learning How to Control Your Type 2 Diabetes, Part 2
September 29, 2014Insulin resistance, Type 2 Diabetes, metabolic syndrome, joint pain, reproductive and hormonal problems, lung problems, sleep disorders, emotional disorders and certain cancers are listed as side effects of being what? If you guessed overweight or obese, you’d be right. Simply lose 5 to 10 percent of your current weight (if you are obese) and all these […]
Omni One, LLC Receives Letter of Intent (LOI)
September 1, 2014Novi, Michigan — SinoPharm of China has issued a letter of intent (LOI) to import Diabetain® and its related technology and other diabetes products from Omni One. This letter of intent stipulates a close collaboration between two companies and implementing a clinical trial in China for a “package drug” status. Diabetain® will be sold in SinoPharm’s many […]
What is Type 2 Diabetes?
August 31, 2014Diabetes Basics: What Is Diabetes?
Diabetes Basics: Fat & Diabetes
Omni One Files U.S. Patent on Diabetain®
August 18, 2014Novi, Michigan — Omni One, LLC, with the support of Michigan Business Accelerator Fund (BAF), has filed a U.S. patent with 26 claims on its product Diabetain®, titled “Nutriceutical combination for prevention and treatment of Type 2 diabetes” on August, 18, 2014. The documents were prepared by its attorneys at Butzel Long based in Detroit, Michigan. Diabetain® is […]